topics

Jun,17 2016
Newly-marketed drug
LOSARHYD COMBINATION TAB. HD「KO」
Jun,19 2015
Newly-marketed drug
CLOPIDOGREL TAB. 25mg「KO」
CLOPIDOGREL TAB. 75mg「KO」
Dec,12 2014
Newly-marketed drug
CANDESARTAN TAB. 2mg「KO」
CANDESARTAN TAB. 4mg「KO」
CANDESARTAN TAB. 8mg「KO」
CANDESARTAN TAB. 12mg「KO」
Jun,20 2014
Newly-marketed drug
CILOSTAZOL OD TAB. 50mg「KO」
CILOSTAZOL OD TAB. 100mg「KO」
PITAVASTATIN CALCIUM TAB. 4mg「KO」
LOSARHYD COMBINATION TAB. LD「KO」
Apr,17 2014
Newly-marketed drug
Suglat Tablets 25mg
Suglat Tablets 50mg
Jan,17 2014
Approval of Suglat Tablets, a Selective SGLT2 Inhibitor for Treatment of Type 2 Diabetes(Joint development with Astellas Pharma Inc.), in Japan
Dec,13 2013
Newly-marketed drug
DONEPEZIL HYDROCHLORIDE OD TAB. 10mg「KO」
PITAVASTATIN CALCIUM TAB. 1mg「KO」
PITAVASTATIN CALCIUM TAB. 2mg「KO」
Nov,18 2013
Anticancer drug (ASP2215) (Phase1, development by Astellas Pharma Inc.)
Anticancer drug (ASP5878) (Phase1, development by Astellas Pharma Inc.)
Jun,21 2013
Newly-marketed drug
PAROXETINE TAB. 5mg「KO」
PRAMIPEXOLE HYDROCHLORIDE TAB. 0.125mg「K0」
PRAMIPEXOLE HYDROCHLORIDE TAB. 0.5mg「K0」
Mar,13 2013
Submits Application for Marketing Approval of Ipragliflozin (ASP1941)/SGLT2 Inhibitor for Treatment of Type 2 Diabetes(Joint development with Astellas Pharma Inc.), in Japan
Dec,14 2012
Newly-marketed drug
OLOPATADINE HYDROCHLORIDE
TAB. 2.5mg「KO」
OLOPATADINE HYDROCHLORIDE
TAB. 5mg「KO」
MOSAPRIDE CITRATE
TAB. 2.5mg「KO」
MOSAPRIDE CITRATE
TAB. 5mg「KO」
Oct,30 2012
We changed development number of cholesterol absorption inhibitor KT6-971 to S-556971.
Jun,22 2012
Newly-marketed drug
PAROXETINE TAB. 10mg「KO」
PAROXETINE TAB. 20mg「KO」
PIOGLITAZONE TAB. 15mg「KO」
PIOGLITAZONE TAB. 30mg「KO」
Nov,28 2011
Donepezil Hydrochloride OD Tablets 3mg「KO」and Donepezil Hydrochloride OD Tablets 5mg 「KO」. It was listed in the drug price list in Japan.
Jul,20 2011
Newly-marketed drug
AZULOXA TAB. 15mg
KIRIGAMIL Nasal Solution 50μg 56 mists.
Jun,24 2011
AZULOXA TAB. 15mg and KIRIGAMIL Nasal Solution 50μg 56 mists.It was listed in the drug price list in Japan.
May,24 2011
We performed an invitation lecture of cholesterol absorption repressor KT6-971 of the new development product in CHINESE ACADEMY SCIENCES.
Nov,19 2010
Newly-marketed drug
FENOFIBRATE CAP. 67mg「KTB」
FENOFIBRATE CAP. 100mg「KTB」
GLIMEPIRIDE TAB. 1mg「KO」
GLIMEPIRIDE TAB. 3mg「KO」
PORATILE 1mg TAB.
May,28 2010
Newly-marketed drug
SARPOGRELATE HYDROCHLORIDE TAB. 50mg「KTB」
SARPOGRELATE HYDROCHLORIDE TAB. 100mg「KTB」
Nov,13 2009
Newly-marketed drug
MARZULENE CONBINATION TABLETS 0.375 ES
Apr,06 2009
AZULOXA granules 2.5%, developed by our company,were launched onto the market together with Ajinomoto Co., Inc.